Medicine and Dentistry
Percutaneous Coronary Intervention
100%
Acute Heart Infarction
70%
Patient
54%
Drug-Eluting Stent
42%
Inpatient
41%
Hazard Ratio
29%
Myocardial Infarction
25%
Cardiovascular System
24%
Rapamycin
15%
Chronic Total Occlusion
15%
Acute Kidney Injury
15%
Combination Therapy
15%
Mortality
14%
Diabetes
13%
Statin
12%
Coronary Artery Disease
12%
Bleeding
11%
Chronic Kidney Disease
11%
All Cause Mortality
11%
Lesion
10%
High Density Lipoprotein Cholesterol
10%
C Reactive Protein
10%
Systolic Blood Pressure
9%
Antiplatelet
9%
Blood Pressure
9%
Clopidogrel
8%
Stent
8%
Follow up
8%
Acute Coronary Syndrome
8%
Stent Thrombosis
8%
Artery
7%
Major Adverse Cardiac Event
7%
Diabetes Mellitus
7%
Cardiovascular Risk
7%
Coronary Artery
7%
Acetylsalicylic Acid
7%
Therapeutic Procedure
6%
Computer Assisted Tomography
6%
Cardiovascular Disease
6%
Association
6%
Antithrombotic
6%
Cause of Death
6%
Low Density Lipoprotein Cholesterol
6%
Heart Death
6%
Endothelial Function
6%
Endothelial Dysfunction
6%
Risk Stratification
6%
Glomerular Filtration Rate
6%
Anemia
6%
Age
6%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Infarction
90%
Heart Infarction
35%
Clopidogrel
30%
Bleeding
22%
Antiplatelet
21%
Acetylsalicylic Acid
16%
Heart Death
16%
Major Adverse Cardiac Event
16%
Ticagrelor
16%
Stent Thrombosis
15%
All Cause Mortality
14%
Acute Heart Infarction
13%
Cause of Death
13%
Chronic Kidney Failure
12%
Brain Ischemia
11%
Stent
10%
Atrial Fibrillation
10%
Coronary Artery Disease
10%
Drug
10%
Heart Infarction
9%
Acute Coronary Syndrome
9%
Cerebrovascular Accident
9%
Statin (Protein)
8%
Anticoagulant Agent
7%
Chronic Total Occlusion
7%
High Density Lipoprotein Cholesterol
7%
Acute Kidney Failure
7%
Low Density Lipoprotein Cholesterol
7%
C Reactive Protein
7%
Acetylsalicylic Acid
7%
Randomized Clinical Trial
6%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
6%
Monotherapy
6%
Mortality
6%
Death
5%
Diabetes Mellitus
5%
No Reflow Phenomenon
5%
Atorvastatin
5%
Cardiovascular Risk
5%
Lung Cancer
5%
Proprotein Convertase 9
5%
Prognosis
5%
Acute Kidney Failure
5%
Phase IV
5%
Aortic Stenosis
5%
Inflammation
5%
Rapamycin
5%
Hemodialysis
5%
Cohort Study
5%
Olmesartan
5%
Nursing and Health Professions
Percutaneous Coronary Intervention
22%
Acute Heart Infarction
19%
Acute Kidney Failure
18%
Clinical Outcome
17%
Hazard Ratio
13%
Percutaneous Coronary Intervention
13%
Confidence Interval
13%
Heart Infarction
12%
Coronary Artery Disease
9%
Confidence Interval
8%
Contrast
7%
Statin (Protein)
7%
Chronic Kidney Failure
6%
Estimated Glomerular Filtration Rate
6%
Acute Heart Infarction
6%
Mortality
5%
Lung Cancer
5%
Rate Ratio
5%
Stent Thrombosis
5%
Treadmill Exercise
5%
Echocardiography
5%
